These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 497276)

  • 21. Depression of histone acetylation by alkylating antitumor agents in murine cells.
    Zwierzina H; Loidl A; Fuith LC; Helliger W; Puschendorf B; Grunicke H
    Cancer Res; 1984 Aug; 44(8):3336-9. PubMed ID: 6744267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
    Ihlenfeldt M; Gantner G; Harrer M; Puschendorf B; Putzer H; Grunicke H
    Cancer Res; 1981 Jan; 41(1):289-93. PubMed ID: 6256062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential enhancement of antitumor effectiveness by phospholipid vesicles (liposomes).
    Ritter C; Iyengar CL; Rutman RJ
    Cancer Res; 1981 Jun; 41(6):2366-71. PubMed ID: 7237434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of the modification of a single-stranded DNA fragment by alkylating derivatives of oligonucleotides].
    Vlasov VV; Knorre DG; Kutiavin IV; Mamaev SV; Podust LM
    Bioorg Khim; 1987 Sep; 13(9):1221-9. PubMed ID: 3426641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
    Cloutier JF; Castonguay A; O'Connor TR; Drouin R
    J Mol Biol; 2001 Feb; 306(2):169-88. PubMed ID: 11237592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional aspects of mono- and poly(ADP-ribosyl)ation: subcellular distribution and ADP-ribosyl turnover under conditions of repair and 'starvation'.
    Hilz H; Wielckens K; Adamietz P; Bredehorst R; Kreymeier A
    Princess Takamatsu Symp; 1983; 13():155-63. PubMed ID: 6654828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA in chromatin is available for sequence-specific chemical modification with oligonucleotide derivatives.
    Kobets ND; Chernolovskaya EL; Borissov RG; Gorozhankin AV; Ivanova EM; Vlassov VV
    Nucleic Acids Symp Ser; 1991; (24):302. PubMed ID: 1841359
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thymidine transport and its incorporation into the cellular DNA of Ehrlich ascites cancer and Zajdela's ascitic hepatoma in the presence of thiophosphamide and thiophosphamide-modified DNA].
    Patskovskiĭ IuV; Voloshchuk TP
    Eksp Onkol; 1989; 11(4):37-41. PubMed ID: 2503349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells.
    Marchut E; Gumińska M; Kedryna T
    Acta Biochim Pol; 1986; 33(1):7-16. PubMed ID: 2940781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal potentiation of the antitumor activity of alkylating drugs.
    Rutman RJ; Ritter CA; Avadhani NG; Hansel J
    Cancer Treat Rep; 1976 May; 60(5):617-8. PubMed ID: 991151
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heterogeniety of the amino acid pool for protein synthesis in Ehrlich ascites carcinoma cells].
    Lishnevskaia EB; Gorozhankina IS; Kotsegub VV
    Biokhimiia; 1984 Jul; 49(7):1073-9. PubMed ID: 6477981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the neutral lipid composition of the liver and tumor cell nucleus during x-irradiation of animals].
    Pal'mina NP; Mal'tseva EL; Burlakova EB
    Radiobiologiia; 1983; 23(6):743-8. PubMed ID: 6657933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological protection mechanisms of radioprotectors in mammalian cells. 13. Effects of AET and serotonin on the DNA content of Ehrlich tumor cell nuclei.
    Kobayashi J; Morino K; Mano H; Asai I
    Tokushima J Exp Med; 1970 Nov; 17():91-6. PubMed ID: 5489634
    [No Abstract]   [Full Text] [Related]  

  • 34. [The mechanism of the interaction of the pH-dependent cytostatic cauloside C with the membranes of tumor cells and liposomes].
    Prokof'eva NG; Likhatskaia GN; Aminin DL; Gafurov IuM; Sasunkevich VA; Strigina LI; Anisimov MM
    Izv Akad Nauk SSSR Biol; 1990; (3):338-42. PubMed ID: 2401767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nucleic acid synthesis in the cells of some ascites tumors induced by change in ionic homeostasis].
    Kaz'min SD
    Biokhimiia; 1981 Jul; 46(7):1226-35. PubMed ID: 7272352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selective modification of polyadenyl fragments of mRNA from Krebs-2 ascites carcinoma cells by an alkylating derivative of nonathymidilyluridine].
    Ivanova EM; Karpova GG; Knorre DG; Popova VS; Raĭt AS
    Mol Biol (Mosk); 1984; 18(3):613-9. PubMed ID: 6472262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of formation of malonic dialdehyde during liposome interaction with cells].
    Konev VV; Popov GA
    Biokhimiia; 1988 Sep; 53(9):1439-42. PubMed ID: 3203106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of nucleic acid secreted by Ehrlich ascites carcinoma cells].
    Agliullina DG; Vegner EO; Lapina LA; Vinter VG
    Eksp Onkol; 1984; 6(2):29-32. PubMed ID: 6510331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phospholipid composition of liver and Ehrlich ascites carcinoma cell nuclei during tumor growth and after irradiation of tumor hosts].
    Pal'mina NP; Mal'tseva EL
    Biokhimiia; 1982 Jan; 47(1):115-25. PubMed ID: 7066414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake and oxidation of elaidic acid by Ehrlich ascites tumor cells.
    Awad AB
    Cancer Biochem Biophys; 1981; 5(2):111-7. PubMed ID: 7248917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.